[1]桂明泰,曹 慧,钱 佳,等.加味越鞠丸对高血压患者颈动脉粥样硬化、血脂及炎性因子的影响[J].陕西中医,2022,(2):181-184.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.009]
 GUI Mingtai,CAO Hui,QIAN Jia,et al.Effect of modified Yueju pill on carotid atherosclerosis,lipid and inflammatory factors in hypertensive patients[J].,2022,(2):181-184.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.009]
点击复制

加味越鞠丸对高血压患者颈动脉粥样硬化、血脂及炎性因子的影响
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年2期
页码:
181-184
栏目:
临床研究
出版日期:
2022-02-05

文章信息/Info

Title:
Effect of modified Yueju pill on carotid atherosclerosis,lipid and inflammatory factors in hypertensive patients
作者:
桂明泰曹 慧钱 佳姚 磊周训杰芦 波符德玉
(上海中医药大学附属岳阳中西医结合医院,上海 200437)
Author(s):
GUI MingtaiCAO HuiQIAN JiaYAO LeiZHOU XunjieLU BoFU Deyu
(Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China)
关键词:
原发性高血压 颈动脉粥样硬化 加味越鞠丸 空腹血糖 血脂 炎性因子
Keywords:
Essential hypertension Carotid atherosclerosis Modified Yueju pill Fasting plasma glucose Lipid Inflammatory factors
分类号:
R 544.1
DOI:
DOI:10.3969/j.issn.1000-7369.2022.02.009
文献标志码:
A
摘要:
目的:评价加味越鞠丸对痰瘀互结证高血压患者颈动脉粥样硬化(CAS)、血脂及炎性因子的影响,为中西医结合防治高血压靶器官损害提供一定的依据。方法:筛选痰瘀互结证高血压伴CAS患者,选用随机、对照、双盲、单模拟剂的研究方法,在原有降压药物及辛伐他汀的基础上,治疗组给予加味越鞠丸颗粒剂,对照组给予加味越鞠丸安慰剂,疗程24周,治疗前后检测颈动脉超声、空腹血糖、血脂及炎性因子,并对结果进行统计分析。结果:①治疗组颈动脉内膜中层厚度及斑块厚度均较治疗前减少(P<0.01),对照组患者治疗前后比较,差异无统计学意义(P>0.05)。②治疗组总胆固醇较治疗前降低(P<0.05),高密度脂蛋白较治疗前升高(P<0.05),且组间比较差异有统计学意义(P<0.01),与对照组比较,差异均无统计学意义(P>0.05); 两组患者空腹血糖较治疗前均有升高(P<0.05),组间比较差异无统计学意义(P>0.05)。③两组超敏C反应蛋白较治疗前均减少(P<0.05)。结论:加味越鞠丸能有效改善高血压患者CAS,改善脂代谢,并有一定的抗炎作用。
Abstract:
Objective:To evaluate the effect of modified Yueju pill on carotid atherosclerosis,lipid and inflammatory factors in hypertensive patients with phlegm and blood stasis syndrome.Then a certain basis for the prevention and treatment of hypertension with integrated Chinese and western medicine will be provided.Methods:Hypertensive patients with phlegm and stasis syndrome were screened,and randomized,controlled,double-blind,single-simulant methods were used.The antihypertensive drugs,simvastatin and granules of modified Yueju pill were given to the patients in treatment group,while antihypertensive drugs,simvastatin and placebo of modified Yueju pill were given to the patients in control group for a total treatment period of 24 weeks.Carotid artery ultrasound,fasting plasma glucose,blood lipids and inflammatory factors were detected at the beginning and end of the study.The results were collected for statistical analysis.Results:①The carotid artery intima-media thickness and plaque thickness in the treatment group were significantly reduced compared with before treatment(P<0.01),and there was no difference in the control group(P>0.05).②Total cholesterol in the treatment group was lower than before treatment(P<0.05),high density lipoprotein was higher than before treatment and there were significant differences between the groups(P<0.01),and there was no difference in the control group(P>0.05).The fasting plasma glucose of both groups was higher than before treatment(P<0.05),there was no difference between groups(P>0.05).③The hypersensitive C-reactive protein in the both group were reduced compared with that before treatment(P<0.05).Conclusion:Modified Yueju pill can effectively improve the CAS in hypertensive patients,improve lipid metabolism,and has a certain anti-inflammatory effect.

参考文献/References:

[1] Guan S,Fang X,Gu X,et al.Bidirectional association between depressive symptoms and carotid atherosclerosis in community-based older adults in China[J].Archives of Gerontology and Geriatrics,2019(83):1-6.
[2] Caruso G,Fresta C,Grasso M,et al.Inflammation as the common biological link between depression and cardiovascular diseases:Can carnosine exert a protective role?[J].Current Medicinal Chemistry,2020,27(11):1782-1800.
[3] 李 杰,朱林德.氟哌噻吨美利曲辛片对高血压合并焦虑抑郁患者血压变异性及动态动脉硬化指数的影响[J].安徽医学,2018,39(8):960-965.
[4] 桂明泰,符德玉,周训杰,等.546例高血压病患者颈动脉硬化分布特征及其与中医证候的相关性初探[J].辽宁中医杂志,2013,40(9):1752-1754.
[5] 符徳玉,赵彦功,任敏之,等.高血压证型与靶器官损害的相关性研究[J].中医药学刊,2004,22(11):2087-2088.
[6] 桂明泰,符德玉,姚 磊,等.高血压病患者中医症状因子分析[J].上海中医药大学学报,2013,27(3):28-30.
[7] 周训杰,姚 磊,符德玉,等.加味越鞠丸对高血压患者胰岛素抵抗及生活质量的干预[J].中西医结合心脑血管病杂志,2013,11(1):10-12.
[8] 中国高血压防治指南修订委员会.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.
[9] 郭万学.超声医学[M].6版.北京:人民军医出版社,2011:689.
[10] 国家食品药品监督管理总局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:30-31.
[11] Kosta T,Boon RA.Endothelial cell metabolism in atherosclerosis[J].Frontiers in Cell & Developmental Biology,2018(6):82.
[12] Yu XH,Qian K,Jiang N,et al.ABCG5/ABCG8 in cholesterol excretion and atherosclerosis[J].Clinica Chimica Acta,2014,428(2):82-88.
[13] 刘俊田.动脉粥样硬化发病的炎症机制的研究进展[J].西安交通大学学报:医学版,2015,36(2):141-152.
[14] 朱晓平,罗文强,南 方,等.胱抑素C、血脂及血糖联合检测对动脉粥样硬化患者的诊断价值[J].陕西医学杂志,2017,46(9):1293-1317.
[15] 王 君,席新龙,郑明娟,等.健康体检者颈动脉粥样硬化与同型半胱氨酸、血脂、血糖水平相关性研究[J].陕西医学杂志,2018,47(5):600-603.
[16] Clarke R,Du H,Kurmi O,et al.Burden of carotid artery atherosclerosis in Chinese adults:Implications for future risk of cardiovascular diseases[J].European Journal of Preventive Cardiology,2017,24(6):647-656.
[17] Savji N,Rockman CB,Skolnick AH,et al.Association between advanced age and vascular disease in different arterial territories:A population database of over 3.6 million subjects[J].Journal of Vascular Surgery,2013,58(6):1719-1720.
[18] Meschia JF,Klaas JP,Brown RD,et al.Evaluation and management of atherosclerotic carotid stenosis[J].Mayo Clin Proc,2017,92(7):1144-1157.
[19] 曾 理,杨鑫荣,余新堂.彩色多普勒超声对脑梗死患者颈动脉粥样硬化斑块的诊断价值[J].中国实用神经疾病杂志,2015,18(6):78.
[20] 《老年人颈动脉粥样硬化性疾病诊治中国专家建议》写作组,中华医学会老年医学分会,《中华老年医学杂志》编辑委员会.老年人颈动脉粥样硬化性疾病诊治中国专家建议[J].中华老年医学杂志,2013,32(2):113-120.
[21] 谢盈或,张军平,仲爱芹.从痰瘀立论探讨分期治疗颈动脉粥样硬化[J].中华中医药杂志,2017,32(1):101-104.
[22] 吴 瑜,李新梅,卓剑丰,等.191例颈动脉粥样硬化患者中医辨证分型与医学相关因素分析[J].中医药导报,2017,23(14):83-85.
[23] 余阳洋,倪 伟,陈咸川.老年高血压合并颈动脉硬化痰湿内蕴证与脂代谢紊乱关系初探[J].陕西中医,2015,36(9):1118-1119.
[24] 何皓頲,高雅琦,叶穗琳.老年收缩期高血压中医证型与颈动脉硬化的临床研究[J].广州中医药大学学报,2008,25(5):461-463.
[25] 王 佩,周 华,杨 涛,等.原发性高血压病人中医体质与颈动脉硬化相关性的研究[J].中西医结合心脑血管病杂志,2017,15(3):267-270.
[26] 陈学彬,宁小康.麝香保心丸对老年冠心病合并颈动脉粥样硬化斑块患者血清hs-CRP、VEGF、MMP-9水平及血脂的影响[J].陕西中医,2017,38(4):427-429.
[27] 徐邦杰,符德玉,周训杰,等.活血潜阳方对高血压血瘀阳亢痰浊型患者胰岛素抵抗及颈动脉斑块的干预作用[J].上海中医药大学学报,2015,29(4):20-23.
[28] 柏晓莉,李慧敏,刘 冰,等.不同剂量辛伐他汀联合曲美他嗪对老年慢性心力衰竭患者心功能、血脂及炎性因子的影响[J].中国老年学杂志,2019,39(23):5657-5659.

相似文献/References:

[1]白起君,黄 捷Δ,周晓亚 ,等.清眩补肾汤治疗原发性高血压疗效及对患者肾素血管紧张素醛固酮影响*[J].陕西中医,2019,(3):311.
 BAI Qijun,HUANG Jie,ZHOU Xiaoya,et al.Effect of Qingxuan Bushen decoction on reninangiotensinaldosterone system of primary hypertension patients[J].,2019,(2):311.
[2]王 菲,蔡 峥△.柴胡加龙骨牡蛎汤加减治疗老年原发性高血压疗效及对患者内皮损伤标志物水平和血压水平影响[J].陕西中医,2019,(9):1261.
 WANG Fei,CAI Zheng..Effect of Chaihu Jia Longgumuli decoction on the level of endothelial injury markers and blood pressure in elderly patients with essential hypertension[J].,2019,(2):1261.
[3]崔秀卿,王志刚△,王素玉,等.耳穴贴压联合涌泉穴按摩对老年原发性高血压患者血压变异性的影响*[J].陕西中医,2020,(7):878.[doi:DOI:10.3969/j.issn.10007369.2020.07.011]
 CUI Xiuqing,WANG Zhigang,WANG Suyu,et al.Effect of auricular point sticking and Yongquan point massage on blood pressure variability in elderly patients with essential hypertension[J].,2020,(2):878.[doi:DOI:10.3969/j.issn.10007369.2020.07.011]
[4]李 英,蔡英剑,王敬斌,等.半夏白术天麻汤联合隔药灸治疗痰湿壅盛证原发性高血压临床研究[J].陕西中医,2021,(10):1385.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.015]
[5]吉 锋,李展绒,任耀龙,等.化痰通瘀除痹方治疗冠心病合并颈动脉粥样硬化斑块痰瘀困阻证疗效研究[J].陕西中医,2022,(9):1212.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.013]
[6]张卫丽,张卫红,刘海立,等.基于ox-LDL信号通路探讨桑芪滋阴补肾汤对人脐静脉血管内皮细胞的影响及其作用机制[J].陕西中医,2023,(9):1193.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.007]
 ZHANG Weili,ZHANG Weihong,LIU Haili,et al.The effect of ox-LDL signaling pathway on the occurrence and development of carotid atherosclerosis in hypertension under the regulation of Sangqi Ziyin Bushen decoction and its mechanism[J].,2023,(2):1193.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.007]
[7]吴文玉,蓝婉宁,吴 鹏,等.脏腑推拿治疗痰湿中阻型原发性高血压眩晕理论研究[J].陕西中医,2024,(3):373.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.019]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81774111); 上海市卫健委科研项目(20184Y0285); 上海市科学技术委员会科研计划项目(19401970400); 上海市中医重点专科培育项目
更新日期/Last Update: 2022-02-09